62.99

11.58% -8.25

After Hours: 63.00 0.010 +0.02%

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $62.99, with a volume of 3.45M. It is down -11.58% in the last 24 hours and down -20.07% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$71.24

Open:

$64

24h Volume:

3.45M

Relative Volume:

5.02

Market Cap:

$3.16B

Revenue:

$1.36B

Net Income/Loss:

$123.81M

P/E Ratio:

26.14

EPS:

2.41

Net Cash Flow:

$20.35M

1W Performance:

-9.33%

1M Performance:

-20.07%

6M Performance:

-26.93%

1Y Performance:

-18.30%

1-Day Range:

$61.43

$65.96

1-Week Range:

$61.43

$71.51

52-Week Range:

$61.43

$97.97

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1177)

Industry

Medical Instruments & Supplies (62)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,657

Twitter

@HaemoneticsCorp

Next Earnings Date

2024-11-07

Latest SEC Filings

HAE's Discussions on Twitter

Compare HAE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HAE Haemonetics Corp	62.99	3.16B	1.36B	123.81M	20.35M	2.41
ISRG Intuitive Surgical Inc	588.50	209.89B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	227.21	68.23B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	91.65	45.33B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	237.18	34.84B	4.93B	1.25B	1.38B	8.47
WST West Pharmaceutical Services Inc	330.47	23.97B	2.88B	499.60M	321.60M	6.74

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-24	Initiated	JP Morgan	Overweight
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-13-24	Initiated	CL King	Buy
Sep-11-24	Initiated	BofA Securities	Neutral
Sep-10-24	Initiated	BTIG Research	Buy
Jun-12-24	Upgrade	Needham	Hold → Buy
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Feb 06, 2025

Earnings call transcript: Haemonetics Q3 2024 sees EPS beat, stock drops - Investing.com Nigeria

Feb 06, 2025

Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 28, 2024 - Marketscreener.com

Feb 06, 2025

Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Feb 06, 2025

Haemonetics (NYSE:HAE) Releases FY 2025 Earnings Guidance - MarketBeat

Feb 06, 2025

Haemonetics earnings beat by $0.02, revenue fell short of estimates - Investing.com

Feb 06, 2025

Haemonetics Corp Q3 Earnings: EPS at $0.74 Misses Estimates, Rev - GuruFocus.com

Feb 06, 2025

Haemonetics: Fiscal Q3 Earnings Snapshot -February 06, 2025 at 06:40 am EST - Marketscreener.com

Feb 06, 2025

Haemonetics Corp Reports Q3 Revenue Of $348.5 Million, Up 3.7% YoY -February 06, 2025 at 06:29 am EST - Marketscreener.com

Feb 06, 2025

Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates - Yahoo Finance

Feb 06, 2025

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Quantisnow

Feb 06, 2025

Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow By Stock Story - Investing.com Canada

Feb 05, 2025

Haemonetics FY2027 EPS Forecast Reduced by Zacks Research - MarketBeat

Feb 05, 2025